Cooper C. Collins bought $7,099 of TXMD
director at TherapeuticsMD, Inc.. 4,094 shares at an average of $1.73, traded Aug 22, 2024, filed Aug 26, 2024.
Score components
- +15RoleDirector
- 0Trade size$7k at market
- +3Relative to holdingsHoldings up 9%
- +8Price context57% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.3%, 3m -26.5%, 6m -47.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-24-002363, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 22, 2024 | POpen-market purchase Common Stock | +4,094 | $1.73 | $7,099 | 52,016 | Aug 26, 2024 |
Related signals
Other insiders at TherapeuticsMD, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | TXMDbuy TherapeuticsMD, Inc. | Tommy G Thompson director | $14k 8,400 shares | +57% | |
| 33Weak | TherapeuticsMD, Inc. | Marlan D Walker Chief Executive Officer | $489 490 shares | +1% | |
| 23Weak | TherapeuticsMD, Inc. | Tommy G Thompson director | $326 325 shares | +2% | |
| 33Weak | TherapeuticsMD, Inc. | Marlan D Walker Chief Executive Officer | $1,994 2,303 shares | +3% | |
| 23Weak | TXMDbuy TherapeuticsMD, Inc. | Cooper C. Collins director | $2,039 1,200 shares | +3% | |
| 21Weak | TXMDsell TherapeuticsMD, Inc. | Marlan D Walker Chief Executive Officer | $44k 19,050 shares | -23% | |
| 30Weak | TherapeuticsMD, Inc. | Brian Bernick Co-Chief Executive Officer | $6,621 1,255 shares | -24% | |
| 27Weak | TherapeuticsMD, Inc. | Michael C Donegan Interim CFO/CAO/VP of Finance | $4,345 910 shares | -17% | |
| 35Weak | TherapeuticsMD, Inc. | Mark A Glickman Co-Chief Executive Officer | $2,165 440 shares | -25% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.